Ambiq Micro, Inc.
NYSE:AMBQSemiconductors
+$5.10 today
- Market cap
- $1.14B
- Beta
- 5.68
- P/E (TTM)
- -44.8
- EPS (TTM)
- -$1.88
Volume 0.30M
Average 0.58M
AMBQ Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Ambiq Micro, Inc.NYSE: AMBQ
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures dips below year-ago levels
Q1 FY2026 capital expenditures of $584K (cash outflow) fell 47.7% year over year, behind the +34.9% change in trailing-twelve-month capital expenditures. Sequentially, it rose 220.9% from the prior quarter.
Context
- Capital expenditures amounted to 1.9% of revenue in FY2025, down 3.1 pp from a year earlier.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -47.7% toward the trailing-twelve-month pace of +34.9%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (1.34M) USD
- Year-over-year change
- +64.0%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.34M) | +64.0% |
| FY2024 | 2024-12-31 | (3.73M) | -23.5% |
| FY2023 | 2023-12-31 | (3.02M) | — |
| FY2021 | 2021-12-31 | (4.62M) | -0.7% |
| FY2020 | 2020-12-31 | (4.59M) | — |
Capital Expenditures vs competitors
How AMBQ compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +34.9% is the 4th highest of 10, against a peer median of -9.9%.
- Capital expenditures amounts to 4.3% of revenue for AMBQ, versus a peer median of 4.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $387.1M USD | -72.5% | +25.8% | 54.3% | |
| LTM Jun 2026 | $13.8M USD | +627.7% | -40.5% | 11.0% | |
| LTM Mar 2026 | $13.38M USD | +126.0% | -6.3% | 4.4% | |
| LTM Mar 2026 | $9.02M USD | +3.8% | -33.5% | 6.0% | |
| LTM Apr 2026 | $8.87M USD | -9.9% | +7.6% | 2.8% | |
| LTM Mar 2026 | $4.17M USD | -43.6% | -9.2% | 295.5% | |
AMBQAmbiq Micro, Inc. | LTM Mar 2026 | $3.5M USD | +34.9% | — | 4.3% |
| LTM Mar 2026 | $2.47M USD | -17.8% | -8.6% | 1.0% | |
| LTM Mar 2026 | $1.5M USD | +382.3% | +9.7% | 1.9% | |
| LTM Mar 2026 | $243K USD | -85.3% | +16.9% | 0.6% | |
NBPNovaBridge Biosciences | LTM Sep 2025 | CN¥41 CNY | — | -94.7% | — |
| Peer median (excluding AMBQ) | — | -9.9% | -7.4% | 4.4% | |
Competitors are the stored peer set for AMBQ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2020 Dec 2020 | FY2021 Dec 2021 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (25.22M) | (25.34M) | (50.33M) | (39.66M) | (36.46M) |
| Depreciation & Amortization | 1.93M | 2.61M | 7.72M | 6.25M | 7.22M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 702K | 1.29M | 2.62M | 5.17M | 6.84M |
| Change in Working Capital | (16.89M) | (36.58M) | 12.91M | 5.11M | 3.47M |
| Accounts Receivables | (136K) | (10.88M) | (2.98M) | 1.75M | 3.23M |
| Inventory | (3.61M) | (26.46M) | 15.16M | 6.04M | (2.13M) |
| Accounts Payables | (1.55M) | 8.23M | (3.94M) | 821K | 4.2M |
| Other Working Capital | (11.59M) | (7.46M) | 4.67M | (3.51M) | (1.82M) |
| Other Non-Cash Items | 4.84M | 5.14M | 125K | 1.7M | (753K) |
| Operating Cash Flow | (34.64M) | (52.88M) | (26.96M) | (21.43M) | (19.69M) |
| Capital Expenditures | (4.59M) | (4.62M) | (3.02M) | (3.73M) | (1.34M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (1.96M) | 0 | (2.56M) | (3.07M) | (6.1M) |
| Investing Cash Flow | (4.59M) | (4.62M) | (3.02M) | (3.73M) | (7.44M) |
| Debt Repayment | 8.77M | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 58.84M | 109.21M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (2.35M) | 354K | 516K | 0 | (2.83M) |
| Financing Cash Flow | 94.07M | 18.2M | 31.77M | 58.84M | 106.38M |
| Effect of Forex Changes | (53K) | 176K | (254K) | (24K) | 43K |
| Net Change in Cash | 54.78M | (39.13M) | 1.54M | 33.66M | 79.29M |
| Free Cash Flow | (39.23M) | (57.5M) | (29.98M) | (25.16M) | (21.03M) |
Ambiq Micro, Inc.
NYSE:AMBQ
Intrinsic Alpha fair value
Locked
Current Price
$45.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.